SARS-CoV-2 Infection
Showing NaN - NaN of 6
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b5 Bivalent (WT/OMI BA.2), BNT162b2 Bivalent (WT/OMI BA.1))
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b5 Bivalent (WT/OMI BA.2)
- BNT162b2 Bivalent (WT/OMI BA.1)
-
Anaheim, California
- +9 more
Aug 8, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
COVID on Children and Families
Recruiting
- SARS-CoV-2 Infection
-
Birmingham, Alabama
- +64 more
May 5, 2022
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- BNT162b2.B.1.351
-
Oakland, California
- +16 more
Feb 17, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
-
Anaheim, California
- +20 more
Feb 17, 2022